143 related articles for article (PubMed ID: 22466460)
1. The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application.
Pournaras CJ; Petropoulos IK; Pournaras JA; Stangos AN; Gilodi N; Rungger-Brändle E
Retina; 2012 Sep; 32(8):1566-73. PubMed ID: 22466460
[TBL] [Abstract][Full Text] [Related]
2. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
[TBL] [Abstract][Full Text] [Related]
3. [Experiment study of infusing tPA in retinal vein for treatment of retinal vein occlusion].
Hu YT; Ma ZZ; Zhang XL; Han SY; Huang LJ
Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):645-9. PubMed ID: 14766057
[TBL] [Abstract][Full Text] [Related]
4. Video microscope recording of the dynamic course of thrombosis and thrombolysis of the retinal vein in rabbits.
Wu J; Zhou X; Hu Y; Zhang T; Ma Z; Li X; Su L; Wang J; Lin S
Retina; 2010 Jun; 30(6):966-70. PubMed ID: 20094009
[TBL] [Abstract][Full Text] [Related]
5. Experimental endoscopic endovascular cannulation: a novel approach to thrombolysis in retinal vessel occlusion.
Hattenbach LO; Puchta J; Hilgenberg I
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):42-6. PubMed ID: 22131392
[TBL] [Abstract][Full Text] [Related]
6. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
Lahey JM; Fong DS; Kearney J
Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
[TBL] [Abstract][Full Text] [Related]
9. Central retinal vessel blood flow after surgical treatment for central retinal vein occlusion.
Crama N; Gualino V; Restori M; Charteris DG
Retina; 2010; 30(10):1692-7. PubMed ID: 20706174
[TBL] [Abstract][Full Text] [Related]
10. Vasomotor effect of intravitreal juxta-arteriolar injection of L-lactate on the retinal arterioles after acute branch retinal vein occlusion in minipigs.
Mendrinos E; Petropoulos IK; Mangioris G; Tsilimbaris MK; Papadopoulou DN; Geka A; Pournaras CJ
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3215-20. PubMed ID: 21345988
[TBL] [Abstract][Full Text] [Related]
11. Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion.
Mahmoud TH; Peng YW; Proia AD; Davidson M; Deramo VA; Fekrat S
Br J Ophthalmol; 2006 Jul; 90(7):911-5. PubMed ID: 16540487
[TBL] [Abstract][Full Text] [Related]
12. Transient ischemic injury in the rat retina caused by thrombotic occlusion-thrombolytic reperfusion.
Daugeliene L; Niwa M; Hara A; Matsuno H; Yamamoto T; Kitazawa Y; Uematsu T
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2743-7. PubMed ID: 10937592
[TBL] [Abstract][Full Text] [Related]
13. Retinal surgery for treatment of central retinal vein occlusion.
Weiss JN
Ophthalmic Surg Lasers; 2000; 31(2):162-5. PubMed ID: 10743932
[TBL] [Abstract][Full Text] [Related]
14. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator in the treatment of experimental retinal vein occlusion.
Oncel M; Peyman GA; Khoobehi B
Retina; 1989; 9(1):1-7. PubMed ID: 2497501
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal tenecteplase (metalyse) for acute management of retinal vein occlusions.
McAllister IL; Vijayasekaran S; Yu DY
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4910-8. PubMed ID: 23766477
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of central retinal vein occlusion.
Berker N; Batman C
Acta Ophthalmol; 2008 May; 86(3):245-52. PubMed ID: 18494725
[TBL] [Abstract][Full Text] [Related]
18. In vivo retinal vascular cannulation in rabbits.
Suzuki Y; Matsuhashi H; Nakazawa M
Graefes Arch Clin Exp Ophthalmol; 2003 Jul; 241(7):585-588. PubMed ID: 12819977
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatments of central retinal vein occlusion.
Parodi MB; Lanzetta P; Guarnaccia G; Friberg T
Semin Ophthalmol; 2003 Sep; 18(3):142-6. PubMed ID: 15513475
[TBL] [Abstract][Full Text] [Related]
20. Indocyanine green as useful guide for retinal vein cannulation and injection of tissue plasminogen activator in rabbits.
Suzuki K; Suzuki Y; Mizukoshi S; Metoki T; Nakazawa M
Tohoku J Exp Med; 2008 Apr; 214(4):351-8. PubMed ID: 18441511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
